Clinical trial Recruiting at 11 sites Observational Ages 18 to 100

Registry for patients with heart failure using pulmonary artery pressure monitors

Official title: Hemodynamic Frontiers in Heart Failure Registry

Run by University of Kansas Medical Center · NCT06425848 · Data updated 2026-11-12

This study is collecting information from patients with heart failure who have special sensors in their lungs to help improve treatment and understanding of their condition.

More Heart Failure trials

Quick facts

Study typeObservational
Ages18 Years to 100 Years
SexAll
Enrollment2000 (estimated)
SponsorUniversity of Kansas Medical Center
Academic / other
Locations12 sites (La Jolla, California and 11 other locations)
StatusRecruiting
StartedOctober 21, 2022
Main results expectedDecember 31, 2030
Study endsDecember 31, 2030
Registry record updatedMay 22, 2024
Trial IDNCT06425848 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults with NYHA Class III heart failure who have had prior hospitalizations or those meeting expanded FDA indications.

Probably not a fit

Patients under 18 years of age, pregnant women, or those unable to maintain continuity of care in a heart failure clinic may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The HF2 Registry aims to collect comprehensive data on patients with heart failure who have been implanted with pulmonary artery pressure sensors. This observational, multi-center registry will gather demographic, clinical, laboratory, and hemodynamic information to enhance understanding of ambulatory hemodynamics monitoring and heart failure therapies. Patients will be recruited from heart failure clinics and will have the option to consent to participate in the registry, which will also facilitate future research opportunities based on the collected data.

Why it matters

Potential benefit: If successful, this registry could lead to improved heart failure management and therapies through better understanding of patient data.

How similar studies have gone: Other studies utilizing similar observational approaches have shown promise in advancing heart failure management, indicating potential for success in this registry.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. All patients would have been or will be implanted per indications from FDA approval/CHAMPION trial. These would be patients with NYHA (New York Heart Association) Class III heart failure who had a prior hospitalization.
2. Patients who meet the expanded FDA indication (BNP elevation without hospitalization or NYHA class II).

Exclusion Criteria:

1. Patients less than 18 years of age.
2. Pregnant women at the scheduled time of PA pressure sensor implant.
3. Patients unable or unwilling to have continuity of care in the heart failure clinic.

Where it's running

  • Scripps Health
    La Jolla, California, United States
    Recruiting
  • Indiana University
    Bloomington, Indiana, United States
    Recruiting
  • University of Kansas Medical Center
    Kansas City, Kansas, United States
    Recruiting
  • Minneapolis Heart Institute Foundation/ Allina Health
    Minneapolis, Minnesota, United States
    Recruiting
  • Saint Luke's Health System
    Kansas City, Missouri, United States
    Recruiting
  • University of North Carolina/ Rex Hospital, Inc.
    Raleigh, North Carolina, United States
    Recruiting
Show 6 more locations
  • Providence Heart Institute
    Portland, Oregon, United States
    Recruiting
  • Prisma Health
    Columbia, South Carolina, United States
    Recruiting
  • Sanford Health
    Sioux Falls, South Dakota, United States
    Recruiting
  • Austin Heart
    Austin, Texas, United States
    Recruiting
  • Houston Methodist DeBakey Heart and Vascular Center
    Houston, Texas, United States
    Recruiting
  • Fairview Health
    Maplewood, Minnesota, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Hirak Shah, MD — University of Kansas Medical Center
  • Study coordinator: Kartik Munshi, MPH
  • Email: kmunshi@kumc.edu
  • Phone: 913-945-6445

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.